pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Verification of Correct Positioning of a Gastric Tube by Ultrasonography
Status: TERMINATED
Conditions: Insertion of a Nasogastric Tube|Intubated Patient|Patients Hospitalized in the Surgery Intensive Care Unit
Interventions: OTHER: ultrasonography|RADIATION: pulmonary radiography
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
Status: RECRUITING
Conditions: Pseudomonas Infections|Pseudomonas Septicemia|Pseudomonas; Pneumonia|Pseudomonal Bacteraemia|Pseudomonas Urinary Tract Infection|Pseudomonas Gastrointestinal Tract Infection|Sepsis|Sepsis, Severe|Critically Ill
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Platform for the Prospective Mother-child Study of the Determinants of Neurodevelopmental Disorders
Status: RECRUITING
Conditions: Autism Spectrum Disorder|Neurodevelopmental Disorders
Interventions: OTHER: Questionnaires|OTHER: Biospecimen collection|OTHER: Neurodevelopmental assessment visit|OTHER: DNA collection
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Esophageal Cooling in Radiofrequency Cardiac Ablation
Status: COMPLETED
Conditions: Atrial Fibrillation
Interventions: DEVICE: EnsoETM|PROCEDURE: Conventional Care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH
Status: COMPLETED
Conditions: Pulmonary Arterial Hypertension
Interventions: DRUG: ESR-specific PET scan
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects
Status: COMPLETED
Conditions: Nausea and Vomiting, Chemotherapy-Induced
Interventions: DRUG: casopitant|DRUG: dolasetron|DRUG: granisetron|DRUG: rosiglitazone
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effects of Reiki on Abdominal Surgery Patients' Anxiety, Fear, Postoperative Pain and Life Findings
Status: COMPLETED
Conditions: Anxiety|Fear|Postoperative Pain|Reiki|Vital Signs
Interventions: OTHER: Reiki
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effects of Walking in Greenspace and the Built Environment in Adults With Prediabetes: A Randomized Crossover Trial
Status: RECRUITING
Conditions: PreDiabetes
Interventions: BEHAVIORAL: Green Walk|BEHAVIORAL: Gray Walk
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Brain Health Together: A Live-Streaming Group-Based Digital Program
Status: ACTIVE_NOT_RECRUITING
Conditions: Mild Cognitive Impairment|Cognitive Decline|Cognitive Deterioration|Cognitive Deficits, Mild|Cognitive Impairment, Mild
Interventions: BEHAVIORAL: Brain Health Academy|BEHAVIORAL: Brain Health Together|BEHAVIORAL: Maintain Brain Health Together
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis
Status: UNKNOWN
Conditions: End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn|Neonatal Jaundice|End Tidal Carbon Monoxide
Interventions: DIAGNOSTIC_TEST: End Tidal Carbon Monoxide Value
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines
Status: UNKNOWN
Conditions: Diffuse Intrinsic Pontine Glioma
Interventions: BIOLOGICAL: Autologous dendritic cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Pharmacokinetics of ODM-209
Status: COMPLETED
Conditions: Prostate Cancer Metastatic|Advanced Breast Cancer|Castration-resistant Prostate Cancer|Metastatic Breast Cancer
Interventions: DRUG: ODM-209
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis
Status: COMPLETED
Conditions: Breast Carcinoma
Interventions: BEHAVIORAL: radiation in prone position|BEHAVIORAL: radiation in supine position
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial
Status: RECRUITING
Conditions: Haloperidol|Advanced Cancer|Hyperactive Delirium|Olanzapine|End-stage Organ Disease
Interventions: DRUG: Haldol 2mg/ml oral solution|DRUG: Olanzapine Actavis 5mg orodispersible tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
Status: COMPLETED
Conditions: Brain and Central Nervous System Tumors
Interventions: BIOLOGICAL: HSPPC-96|PROCEDURE: Standard Surgical Resection
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia
Status: TERMINATED
Conditions: Leukemia|Hodgkin Lymphoma|Lymphoma, Non-Hodgkin's
Interventions: OTHER: PedsQL Cancer Module|OTHER: PedsQL Multidimensional Fatigue Scale|DEVICE: Biodex System 3 Dynamometer|DEVICE: Jamar Hydraulic Hand Dynamometer|OTHER: Sit and Reach Test|OTHER: Test of Motor Proficiency|OTHER: Verbal Numeric Pain Scale|OTHER: :Yoga Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Targeted Temperature Management After In-Hospital Cardiac Arrest
Status: UNKNOWN
Conditions: Hypoxic Ischemic Encephalopathy
Interventions: DEVICE: Arctic Sun®|DEVICE: Arcticgel™|PROCEDURE: Conventional antipyretic treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Castration Levels of Testosterone|Castration-Resistant Prostate Carcinoma|Metastatic Prostate Carcinoma|PSA Progression|Stage IV Prostate Adenocarcinoma AJCC v7
Interventions: DRUG: Abiraterone Acetate|DRUG: Apalutamide|DRUG: Cabazitaxel|DRUG: Carboplatin|BIOLOGICAL: Ipilimumab|OTHER: Laboratory Biomarker Analysis|DRUG: Prednisone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
Status: COMPLETED
Conditions: Coronavirus Infections
Interventions: DRUG: Hydroxychloroquine Oral Product|DRUG: Hydroxychloroquine + azithromycin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration
Status: COMPLETED
Conditions: Neovascular Age-related Macular Degeneration
Interventions: DIAGNOSTIC_TEST: Blood sampling through direct peripheral venous puncture
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Status: RECRUITING
Conditions: Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Hematopoietic and Lymphoid System Neoplasm|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Chronic Myeloid Leukemia, BCR-ABL1 Positive
Interventions: PROCEDURE: Biospecimen Collection|PROCEDURE: Bone Marrow Aspirate|DRUG: Cyclophosphamide|DRUG: Cyclosporine|PROCEDURE: Diagnostic Imaging|PROCEDURE: Echocardiography|DRUG: Fludarabine Phosphate|PROCEDURE: Multigated Acquisition Scan|DRUG: Mycophenolate Mofetil|OTHER: Survey Administration|DRUG: Thiotepa|RADIATION: Total-Body Irradiation|PROCEDURE: Umbilical Cord Blood Transplantation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intracameral Antibiotic Safety Study
Status: SUSPENDED
Conditions: Intracameral Antibiotics|Cataract Surgery|Phacoemulsification|Endophthalmitis|Vancomycin|Moxifloxacin
Interventions: DRUG: Vancomycin|DRUG: Moxifloxacin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers
Status: COMPLETED
Conditions: Alzheimer Disease|Dementia|Brain Diseases|Central Nervous System Diseases|Nervous System Diseases|Tauopathies|Neurodegenerative Diseases|Neurocognitive Disorders|Mental Disorders
Interventions: BEHAVIORAL: Harmony at HOME (H@H)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Interdisciplinary Intervention Versus Brief Intervention for Patients With Musculoskeletal Pain
Status: COMPLETED
Conditions: Musculoskeletal Diseases
Interventions: BEHAVIORAL: Interdisciplinary intervention|BEHAVIORAL: Control Group, Brief Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Glutenfree, Gut Microbiota and Metabolic Regulation
Status: COMPLETED
Conditions: Celiac Disease
Interventions: DIETARY_SUPPLEMENT: Randomized, controlled trial (RCT) with parallel arms and double blinded
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
Status: COMPLETED
Conditions: Prostate Cancer
Interventions: DRUG: Enzalutamide|DRUG: Bicalutamide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration
Status: COMPLETED
Conditions: Trichuriasis|Ascariasis|Hookworm Infections|Helminthes; Infestation, Intestinal
Interventions: DRUG: moxidectin (8 mg) / albendazole (400 mg)|DRUG: ivermectin (200 µg/kg) / albendazole (400 mg)|DRUG: ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL]|DRUG: ivermectin (200 µg/kg)|DRUG: moxidectin (8 mg)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE)
Status: COMPLETED
Conditions: Corona Virus Infection|Covid19|COVID-19
Interventions: PROCEDURE: Awake Proning
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment
Status: ACTIVE_NOT_RECRUITING
Conditions: Locally Advanced or Metastatic Medullary Thyroid Cancer|Medullary Thyroid Cancer
Interventions: BEHAVIORAL: Patient outreach|DRUG: Vandetanib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)
Status: TERMINATED
Conditions: Leukemia, Myeloid, Acute
Interventions: DRUG: Plerixafor|DRUG: Mitoxantrone|DRUG: Etoposide|DRUG: Cytarabine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding
Status: COMPLETED
Conditions: Esophageal and Gastric Varices
Interventions: DRUG: carvedilol|DRUG: cyanoacrylate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism
Status: RECRUITING
Conditions: Hyperopia
Interventions: DEVICE: TENEO 317 Model 2 excimer laser
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication: Clinical Study
Status: COMPLETED
Conditions: Bacterial Viability of Necrotic Pulp With Asymptomatic Apical Periodontitis
Interventions: DRUG: Glycyrrhizin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Erector Spinae Plane Block Versus Intraarticular Injection for Postoperative Analgesia in Shoulder Arthroscopy
Status: COMPLETED
Conditions: Shoulder Arthroscopy|Postoperative Analgesia|Erector Spinae Plane Block|Intraarticular Injection
Interventions: PROCEDURE: Erector Spinae Plane Block|PROCEDURE: Intraarticular Injection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Feasibility of the Comfort Measures Only Time Out (CMOT)
Status: RECRUITING
Conditions: End of Life|Respiratory Failure|Ventilatory Failure|Coma|Aging
Interventions: BEHAVIORAL: Comfort Measures Only Time out (CMOT)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR
Status: UNKNOWN
Conditions: Cardiotoxicity|Osteosarcoma|Myocardial Injury|Chemotherapy Induced Systolic Dysfunction|Doxorubicin Induced Cardiomyopathy
Interventions: DIAGNOSTIC_TEST: contrast-enhanced cardiac magnetic resonance imaging(MAGNETOM Aera 1.5T)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Efficacy, Immunogenicity, and Safety Study of the 9vHPV Vaccine in Japanese Males (V503-064)
Status: ACTIVE_NOT_RECRUITING
Conditions: Warts, Genital|Neoplasms, Anal
Interventions: BIOLOGICAL: V503|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT
Status: COMPLETED
Conditions: Normal|Impaired Fasting Glucose|Impaired Glucose Tolerance
Interventions: DIETARY_SUPPLEMENT: Chitosan Oligosaccharide (GO2KA1)|DIETARY_SUPPLEMENT: White egg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer
Status: UNKNOWN
Conditions: Gastric Cancer
Interventions: DRUG: dexmedetomidine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Uptake and Biodistribution of 89Zirconium-labeled Ipilimumab in Ipilimumab Treated Patients With Metastatic Melanoma
Status: UNKNOWN
Conditions: Melanoma
Interventions: BIOLOGICAL: 89Zirconium-labeled ipilimumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Status: TERMINATED
Conditions: ACE Inhibitor Induced Angioedema
Interventions: DRUG: ecallantide 60 mg|DRUG: ecallantide 30 mg|DRUG: ecallantide 10 mg|DRUG: placebo|DRUG: placebo match for 30 mg ecallantide arm|DRUG: placebo match for 10 mg ecallantide arm
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease
Status: COMPLETED
Conditions: Hepatic Insufficiency
Interventions: DRUG: Alitretinoin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
Clinical trial: Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms
Status: COMPLETED
Conditions: Brain Aneurysm
Interventions: DEVICE: PulseRider
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Status: TERMINATED
Conditions: Adenocarcinoma of the Lung|Recurrent Non-small Cell Lung Cancer|Stage IA Non-small Cell Lung Cancer|Stage IB Non-small Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer
Interventions: DRUG: acetylsalicylic acid|OTHER: laboratory biomarker analysis
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults
Status: NOT_YET_RECRUITING
Conditions: Age-related Cognitive Decline
Interventions: OTHER: Nutritional intervention|OTHER: Physical exercise|OTHER: Cognitive training|OTHER: Oral hygiene|OTHER: Sleep quality|OTHER: Control of cardiovascular, metabolic, and infectious risk factors|OTHER: Pharmacological evaluation|BEHAVIORAL: Socializing|OTHER: Self-administered interventions
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
Status: COMPLETED
Conditions: Influenza
Interventions: DRUG: aQII-1|DRUG: aQII-3 Investigational|DRUG: aQII-6 Investigational|OTHER: aQII-7 Investigational|DRUG: aQII-9 Investigational|DRUG: aQII-10 Investigational|DRUG: aQII-11 Investigational|DRUG: QII Active Comparator
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
Status: COMPLETED
Conditions: Migraine Disorders
Interventions: DRUG: Combination therapy with sumatriptan and naproxen sodium (SumaRT/Nap)|DRUG: Single-entity oral triptans
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Physiological Effects of Lactate in Individuals With Chronic Heart Failure
Status: RECRUITING
Conditions: Heart Failure, Systolic
Interventions: OTHER: Sodium lactate infusion|OTHER: Sodium lactate ingestion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
Status: RECRUITING
Conditions: Intravenous|Thrombosis|Acute Ischemic Stroke
Interventions: DRUG: tenecteplase
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis
Status: COMPLETED
Conditions: Atopic Dermatitis
Interventions: DIETARY_SUPPLEMENT: Vitamin D3|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Status: RECRUITING
Conditions: Melanoma
Interventions: DRUG: SHR-1701|DRUG: Temozolomide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
Status: WITHDRAWN
Conditions: Wet Age-related Macular Degeneration
Interventions: DRUG: Bevacizumab|DRUG: Ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration
Status: UNKNOWN
Conditions: Covid19|Respiratory Tract Infections|Severe Acute Respiratory Syndrome|Corona Virus Infection|RNA Virus Infections|Virus Disease|Respiratory Tract Disease
Interventions: DIAGNOSTIC_TEST: IgM and IgG antibodies assay
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Atezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter Syndrome
Status: RECRUITING
Conditions: Chronic Lymphocytic Leukemia|Recurrent Transformed Chronic Lymphocytic Leukemia|Refractory Transformed Chronic Lymphocytic Leukemia|Richter Syndrome|Small Lymphocytic Lymphoma
Interventions: DRUG: Atezolizumab|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Obinutuzumab|DRUG: Venetoclax
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Time of Permanence of Dressing Following Breast Reconstruction
Status: COMPLETED
Conditions: Surgical Site Infection
Interventions: OTHER: Incisions covered for 1 day|OTHER: Incisions covered for 6 days
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Efficacy of Modified Constraint Induced Movement Therapy Combined With Threshold Electrical Stimulation in Stroke Patients
Status: COMPLETED
Conditions: Stroke
Interventions: OTHER: Modified Constraint Induced Therapy and Threshold Electrical Stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Ophthalmic Artery Resistance Index After Peribulbar Block in the Presence of Epinephrine
Status: COMPLETED
Conditions: Ophthalmic Artery|Peribulbar Block
Interventions: DRUG: Epinephrine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Healthy Lifestyles After Stroke - Stroke Coach
Status: COMPLETED
Conditions: Stroke|Apoplexy|Cerebral Stroke|Cerebrovascular Accident|Cerebrovascular Accident, Acute|Cerebrovascular Apoplexy|Cerebrovascular Stroke|CVA|Stroke, Acute|Vascular Accident, Brain
Interventions: BEHAVIORAL: Healthy Lifestyle Training Program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions
Status: COMPLETED
Conditions: Hemothorax|Hemopneumothorax; Traumatic|Empyema|Chest Tube Size
Interventions: DEVICE: Chest tube placement
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
Status: COMPLETED
Conditions: Mild Cognitive Impairment|Major Depressive Disorder|Alzheimer's Disease
Interventions: DRUG: es-citalopram|DRUG: Memantine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Acid Reflux in Asthma
Status: COMPLETED
Conditions: Asthma|Lung Diseases|Lung Diseases, Obstructive
Interventions: DRUG: Esomeprazole|DRUG: Placebo proton pump inhibitor
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
Status: COMPLETED
Conditions: Bipolar Disorder|Cocaine Dependence|Methamphetamine Dependence
Interventions: DRUG: quetiapine, risperidone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma
Status: UNKNOWN
Conditions: Lymphoma, Non-Hodgkin;Hodgkin Disease
Interventions: DRUG: R-CHOP/CHOPE or ABVD chemotherapy regimen|DRUG: R-CDOP/CDOPE or DBVD chemotherapy regimen
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Neurocytotron on Cerebral Palsy
Status: COMPLETED
Conditions: Cerebral Palsy
Interventions: DEVICE: Neurocytotron|DEVICE: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ponto Implantation Using a Minimally Invasive Surgical Technique
Status: COMPLETED
Conditions: Hearing Loss
Interventions: PROCEDURE: Minimally invasive surgery|OTHER: Glasgow Benefit Inventory (GBI)|OTHER: Additional follow-up visits after surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Status: RECRUITING
Conditions: Metastatic Pancreatic Neuroendocrine Tumor|Pancreatic Neoplasm|Stage III Pancreatic Neuroendocrine Tumor AJCC v8|Stage IV Pancreatic Neuroendocrine Tumor AJCC v8|Unresectable Pancreatic Neuroendocrine Tumor
Interventions: PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|DRUG: Lutetium Lu 177 Dotatate|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Positron Emission Tomography|DRUG: Sunitinib Malate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: 1 tablet Empagliflozin/2 tablets Metformin XR|DRUG: 10 mg Empagliflozin/1000 mg Metformin XR|DRUG: 1 tablet 10 mg Empagliflozin/3 tablets Metformin XR|DRUG: 2 tablets 5 mg Empagliflozin/750 Metformin XR|DRUG: 1 tablet Empagliflozin/2 tablets Metformin XR|DRUG: 10 mg Empagliflozin/1000 mg Metformin XR
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ultrasonographic and Comfort Comparison of Sitting Fetal Cross-legged Position With Lateral Decubitus Fetal Position
Status: COMPLETED
Conditions: Anesthesia, Conduction
Interventions: PROCEDURE: Anatomical intervention with USG and comfort evaluation with NRS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: Ciclesonide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab
Status: COMPLETED
Conditions: Paroxysmal Nocturnal Hemoglobinuria
Interventions: COMBINATION_PRODUCT: Ravulizumab OBDS|BIOLOGICAL: Ravulizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Status: TERMINATED
Conditions: Lymphoma, Non-Hodgkin|Neoplasms
Interventions: DRUG: CC-90011|DRUG: Rifampicin|DRUG: Itraconazole
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial
Status: WITHDRAWN
Conditions: Obesity, Childhood
Interventions: DRUG: Lifestyle Management
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Erector Spinae Block and Incidence of Postoperative Delirium After Hip Fracture Surgeries
Status: NOT_YET_RECRUITING
Conditions: Delirium in Old Age
Interventions: OTHER: CAM score
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Evaluation of the Effectiveness of a Novel Gait Trainer in Increasing the Functionality of Motor Impaired Patients: Pilot Study
Status: COMPLETED
Conditions: To Evaluate Effectiveness of the Gait Trainer in Increasing the Functionality and Spatiotemporal Parameters of Gait of 4 Patients.
Interventions: DEVICE: Walker
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Trial to Determine the Feasibility and Effectiveness of Early Multisensory Stimulation Intervention in Patients in the Trauma-Neurosurgical Intensive Care Unit (TNICU) Following Severe Acquired Brain Injury
Status: TERMINATED
Conditions: Traumatic Brain Injury With Prolonged Loss of Consciousness
Interventions: OTHER: Multisensory Stimulation|OTHER: Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Status: COMPLETED
Conditions: Melanoma (Skin)
Interventions: BIOLOGICAL: aldesleukin|BIOLOGICAL: sargramostim|DRUG: cyclophosphamide|DRUG: fludarabine phosphate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
Status: COMPLETED
Conditions: Amyotrophic Lateral Sclerosis
Interventions: DRUG: Granulocyte Colony Stimulating Factor|DRUG: NS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: SIRT-1 Antagonism for Endometrial Receptivity
Status: WITHDRAWN
Conditions: Endometriosis|Uterine Diseases|Endometrial Diseases|Infertility Unexplained|Infertility; Female, Nonimplantation
Interventions: DRUG: EX-527 (Selisistat)|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava
Status: COMPLETED
Conditions: Nasal Polyps|Nasal Diseases|Papilloma
Interventions: DEVICE: Surgical removal of sinonasal papiloma
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: A Systematic Oral Care Program in Post-Mechanically Ventilated, Post-Intensive Care Patients
Status: COMPLETED
Conditions: Methicillin-resistant Staphylococcus Aureus|Methicillin-Sensitive Staphylococcus Aureus Infection
Interventions: PROCEDURE: 4-day systematic oral hygiene|OTHER: Standard of Care oral care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
Status: COMPLETED
Conditions: Schizophrenia|Psychotic Disorders
Interventions: DRUG: Aripiprazole|DRUG: Quetiapine|DRUG: Ziprasidone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: US Inhaled Insulin Dose Titration Study
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Exubera (inhaled insulin)|PROCEDURE: 8-point glucose diary (to assess pre- and post prandial glucoses)|PROCEDURE: Meal Tolerance Test|PROCEDURE: 24-hour continuous glucose monitoring (at select sites)|PROCEDURE: Pulmonary Function Testing|PROCEDURE: Hypoglycemic Event Monitoring|PROCEDURE: Laboratory Assessments|BEHAVIORAL: Nutritional Counseling and Diabetes Education
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis
Status: UNKNOWN
Conditions: Psoriasis
Interventions: BIOLOGICAL: FURESTEM-CD Inj.
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Postural Drainage With and Without Percussion in Chronic Obstructive Pulmonary Disease
Status: RECRUITING
Conditions: Chronic Obstructive Pulmonary Disease
Interventions: OTHER: POSTURAL DRAINAGE WITH PERCUSSION|OTHER: Postural drainage
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
Status: COMPLETED
Conditions: Cervical Intraepithelial Neoplasia|Cervical Cancer
Interventions: BIOLOGICAL: 30μg HPV|BIOLOGICAL: 60μg HPV|BIOLOGICAL: 90μg HPV|BIOLOGICAL: Hepatitis B vaccine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Status: COMPLETED
Conditions: Hemorrhagic Fever, Ebola
Interventions: BIOLOGICAL: Ad26.ZEBOV|BIOLOGICAL: MVA-BN-Filo|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory
Status: COMPLETED
Conditions: Schizophrenia
Interventions: DEVICE: repetitive Transcranial Magnetic Stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam
Status: ENROLLING_BY_INVITATION
Conditions: Tobacco Cessation
Interventions: BEHAVIORAL: mHealth Messaging to Motivate Quitline use and Quitting among Persons Living With HIV (PLWH) in Vietnam (M2Q2-HIV)|BEHAVIORAL: M2Q2-HIV Comparison
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effects of Quadratus Lumborum Block on Lower Urinary System Symptoms
Status: ACTIVE_NOT_RECRUITING
Conditions: Lower Urinary Tract Symptoms
Interventions: PROCEDURE: Quadratus lumborum block|PROCEDURE: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: The Effect of a Case-finding App on the Detection Rate of Atrial Fibrillation in Primary Care Patients
Status: NOT_YET_RECRUITING
Conditions: Atrial Fibrillation Paroxysmal
Interventions: DEVICE: FibriCheck
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Status: WITHDRAWN
Conditions: Toxic Epidermal Necrolysis
Interventions: DRUG: Remicaide (infliximab)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole
Status: COMPLETED
Conditions: HNSCC,Larynx, Pharynx and Oral Cavity
Interventions: RADIATION: 76 Gy/ 56 fx/ 10/W with cisplatin 40 mg/m2/W and nimorazole
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children
Status: COMPLETED
Conditions: Respiratory Syncytial Virus
Interventions: DRUG: Azithromycin 10 mg|DRUG: Azithromycin 20mg|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression
Status: UNKNOWN
Conditions: Bipolar Disorder
Interventions: DRUG: Bupropion|DEVICE: Active Repetitive Transcranial Magnetic Stimulation|OTHER: Placebo|DEVICE: Sham repetitive transcranial magnetic stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study To Investigate The Effect of JNJ-39758979 on Histamine Induced Itch in Healthy Male Volunteers
Status: COMPLETED
Conditions: Histamine Induced Itch
Interventions: DRUG: A:JNJ-39758979/Placebo #1|DRUG: C:Cetirizine/JNJ-39758979 Matching Placebo|DRUG: B: JNJ-39758979 Matching Placebo /Placebo #2
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Intensity Modulated Radiotherapy in Recurrent T1-2 Nasopharyngeal Carcinoma
Status: COMPLETED
Conditions: Nasopharyngeal Cancer Recurrent
Interventions: RADIATION: 3D-CRT, IMRT, BT, BT combined 3D-CRT or IMRT
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
Status: TERMINATED
Conditions: Non-obstructive Coronary Artery Disease
Interventions: DRUG: Nicorandil
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases
Status: RECRUITING
Conditions: Peritoneal Carcinomatosis|Pancreas Neoplasm
Interventions: DRUG: Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
Status: UNKNOWN
Conditions: Stage IV Prostate Cancer
Interventions: PROCEDURE: cryoablation|DRUG: Bicalutamide|DRUG: luteinizing-hormone releasing-hormone (LHRH) agonist
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
Status: NOT_YET_RECRUITING
Conditions: Proliferative Diabetic Retinopathy|Diabetic Retinopathy|Diabetic Retinopathy Visually Threatening|Diabetic Macular Edema|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
Interventions: PROCEDURE: Single-session panretinal PRP (SS-PRP)|PROCEDURE: Multiple-session panretinal PRP (MS-PRP)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Therapeutic Use of rTMS in Pediatric ASD and ADHD Cohorts
Status: RECRUITING
Conditions: Autism Spectrum Disorder|ADHD|Neurodevelopmental Disorders
Interventions: DEVICE: repetitive Transcranial Magnetic Stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)
Status: COMPLETED
Conditions: SMA
Interventions: DRUG: Riluzole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea
Status: COMPLETED
Conditions: Sleep Apnea
Interventions: DRUG: Dextromethorphan|DRUG: Caffeine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
Status: RECRUITING
Conditions: Benign Prostate Hypertrophy(BPH)
Interventions: DRUG: CKD-846|DRUG: D091
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impact of Pilates Method on Myofascial Stiffness, Cardiorespiratory Fitness and Quality of Life in Breast Cancer Women
Status: COMPLETED
Conditions: Breast Cancer Female
Interventions: BEHAVIORAL: supervised physical activity intervention using the Pilates Method (exercises on the mat)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Er:YAG Laser Treatment of Moderate Chronic Periodontitis
Status: COMPLETED
Conditions: Chronic Periodontitis, Generalized, Moderate
Interventions: DEVICE: Er:YAG laser|OTHER: hand instruments
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
Status: COMPLETED
Conditions: Alopecia Areata
Interventions: DRUG: Topical latanoprost 0.005%|DRUG: Topical betamethasone 0.05%
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section
Status: COMPLETED
Conditions: Post Partum Haemorrhage
Interventions: DRUG: Misoprostol|DRUG: Oxytocin|DRUG: Oxytocin and Misoprostol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
Status: UNKNOWN
Conditions: Multiple Sclerosis, Chronic Progressive|Multiple Sclerosis, Relapsing-Remitting
Interventions: DRUG: RTL1000 (recombinant T cell receptor ligand)|DRUG: RTL1000 Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer
Status: WITHDRAWN
Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Interventions: DRUG: HS-20093
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT